Atlas Trials

Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain

Clinical trial NCT04126499 · COMPLETED

Trial details

NCT number
NCT04126499
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Severe Eosinophilic Asthma
Start date
2020-01-13
Primary completion
2020-05-08
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.